PHC Group strives to improve product security and reduce the potential for disruptions caused by unauthorized access of our products. This unified policy across group companies, including Ascensia, describes our efforts to deliver products and services that adhere to international standards and industry regulations.
We have implemented a global monitoring system to support prompt action and detailed impact assessment in the event of a security incident.
PHC Group periodically reviews and adjusts processes as needed, analyzes customer feedback, and implements effective and proactive recurrence prevention measures.
PHC Group provides regular training for relevant employees so they have knowledge and awareness of the importance of product security, product standards and how to recognize and respond to potential threats.
Our product security standards incorporate relevant international regulations. These standards are regularly reviewed and adjusted to address potential emerging industry needs or security threats.
In addition to maintaining and enforcing product security standards, PHC Group seeks to minimize security risks by incorporating product security considerations from product planning to development. PHC Group also monitors for potential vulnerabilities in our products and third-party software used in our products, and uses the results to inform the development of updates and countermeasures.
PHC Group will maintain and enhance the safety and security of our products based on this policy.
Through these initiatives, PHC Group will strive to enhance customer satisfaction and advance our mission of contributing to better healthcare for people around world.
Consult the user instructions for Ascensia products, which may include product-specific security information.
Ascensia Diabetes Care also makes Manufacturer Disclosure Statement for Medical Device Security (MDS2) and Software Bill of Materials (SBOM) documentation available for applicable products, including our Blood Glucose Monitoring (BGM) devices and the CONTOUR™DIABETES app (CDA).
MDS2 documentation provides an overview of the security features of a medical device. SBOM documentation identifies software components used within our products, including third-party software and the types of code we use.
Requests for user instructions and MDS2 and SBOM documentation can be submitted through our Customer Service team contact page.
This documentation is available upon request in PDF format for our BGM devices and the CONTOUR™DIABETES app. To obtain a copy, please visit our Customer Service contact page.
To support ongoing monitoring and improvement of our products, you can report potential cybersecurity vulnerabilities to us via our Customer Service contact page.